Bio

Seth Goldsamt advises his U.S. and international clients (including investment funds) on a broad range of mergers and acquisitions, private equity transactions, public and private securities offerings (including PIPE transactions), equity co-investments, joint ventures, mezzanine financings, venture capital, and restructuring transactions. Particularly experienced in representing clients in the technology, media and telecommunications (TMT) and technology/biotechnology industries and in advising on international/cross-border transactions, Seth also advises clients on general corporate matters, various aspects of corporate governance and compliance with federal securities laws. Outside of the office, Seth is an active member of The Danish-American Chamber of Commerce, New York, and has served on its board of directors for several years and, since 2021, has served as its chairman. Seth is a co-founder of, and regular presenter at, the life sciences conference known as DKBIO, which he organizes with The Royal Danish Consulate and the Innovation Centre of Denmark, Boston. DKBIO brings together biotech companies, medical device and technology companies, pharmaceutical companies, business developers and investors from the U.S., Denmark and other Nordic countries for an annual event to build bridges between life science innovation in the Nordic region and the U.S.